+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

India Neuromodulation Devices Market Outlook to 2033 - Implantable Neuromodulation Devices and Non-Invasive Neuromodulation Devices

  • PDF Icon

    Report

  • 43 Pages
  • February 2026
  • Region: India
  • GlobalData
  • ID: 6058731

The India Neuromodulation Devices Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2025 company share data for Neuromodulation Devices Market.
  • Global corporate-level profiles of key companies operating within the India Neuromodulation Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Report Scope

India Neuromodulation Devices is segmented as follows:

  • Implantable Neuromodulation Devices
  • Minimally Invasive Neuromodulation Devices
  • Non-Invasive Neuromodulation Devices

Reasons to Buy

The India Neuromodulation Devices Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Neuromodulation Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Neuromodulation Devices Market, India
3.1 Neuromodulation Devices Market, India, Revenue ($m), 2018-2033
3.1.1 Implantable Neuromodulation Devices Market, India, Revenue ($m), by Segment, 2018-2033
3.2 Neuromodulation Devices Market, India, Volume (Units), 2018-2033
3.2.1 Implantable Neuromodulation Devices Market, India, Volume (Units), by Segment, 2018-2033
3.3 Neuromodulation Devices Market, India, Average Price ($), 2018-2033
3.4 Neuromodulation Devices Market, India, Company Share by Revenue ($m), 2025
4 Overview of Key Companies in India, Neuromodulation Devices Market
4.1 LivaNova Plc
4.1.1 Company Overview
4.2 Boston Scientific Corp
4.2.1 Company Overview
4.3 Medtronic Plc
4.3.1 Company Overview
4.4 Abbott Laboratories
4.4.1 Company Overview
4.5 Enterra Medical Inc
4.5.1 Company Overview
4.6 B. Braun Melsungen AG
4.6.1 Company Overview
5 Neuromodulation Devices Market Pipeline Products
6 Recent Developments
6.1 Corporate Communications
6.1.1 Nov 18, 2025: NeuroSigma Launches Next-Generation Monarch Device for Pediatric ADHD
6.2 Other Significant Developments
6.2.1 Nov 24, 2025: NeuroPace Announces Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services
6.3 Product News
6.3.1 Nov 28, 2025: Yale-Trained Neuroscientist Introduces Panbrain Lume "Digital Sunshine" Device to Improve Sleep
6.3.2 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV
6.3.3 Nov 21, 2025: Brainbox and Sonic Concepts Deliver 100 NeuroFUS Systems Worldwide
6.3.4 Nov 15, 2025: Evidence Builds for Disrupted Mitochondria as Cause of Parkinson’s
6.3.5 Oct 30, 2025: Sant Pau Incorporates MRgFUS Technology For Movement Disorders Without Surgery
6.3.6 Oct 20, 2025: Neupulse Attends Launch of N3 Centre for Neurotechnology
6.3.7 Oct 07, 2025: Oxeia Biopharmaceuticals Recognized As Most Innovative Mild Traumatic Brain Injury Company for 2025
6.3.8 Oct 01, 2025: BalanceWear® for Multiple Sclerosis: Enhance Stability and Mobility
6.3.9 Sep 17, 2025: Soft Bioelectronic Fiber Tracks Hundreds of Biological Events Simultaneously
6.4 Strategy And Business Planning
6.4.1 Nov 25, 2025: NaviFUS Presents Stroke Rehabilitation Data at AOCCN 2025
6.4.2 Nov 21, 2025: Brainbox and Sonic Concepts Deliver 100 NeuroFUS Systems Worldwide
6.4.3 Oct 20, 2025: Neupulse Attends Launch of N3 Centre for Neurotechnology
7 Appendix
7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Market Modeling and Forecasting
7.1.5 Company Share Analysis
7.1.6 Benchmarking
7.2 the analyst Consulting
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
Table 1: Neuromodulation Devices Market, India, Revenue ($m), USD Constant, 2018-2033
Table 2: Implantable Neuromodulation Devices Market, India, Revenue ($m), USD Constant, 2018-2033
Table 3: Neuromodulation Devices Market, India, Volume (Units), 2018-2033
Table 4: Implantable Neuromodulation Devices Market, India, Volume (Units), 2018-2033
Table 5: Neuromodulation Devices Market, India, Average Price ($), 2018-2033
Table 6: Neuromodulation Devices Market, India, Company Share by Revenue ($m), 2025
Table 7: Neuromodulation Devices Market Pipeline Products
Table 8: Total Number of Primary Research Participants, Neurology Devices Market, by Country
List of Figures
Figure 1: Neuromodulation Devices Market, India, Revenue ($m), USD Constant, 2018-2033
Figure 2: Implantable Neuromodulation Devices Market, India, Revenue ($m), USD Constant, 2018-2033
Figure 3: Neuromodulation Devices Market, India, Volume (Units), 2018-2033
Figure 4: Implantable Neuromodulation Devices Market, India, Volume (Units), 2018-2033
Figure 5: Neuromodulation Devices Market, India, Company Share (%), 2025

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • LivaNova Plc
  • Boston Scientific Corp
  • Medtronic Plc
  • Abbott Laboratories
  • Enterra Medical Inc
  • B. Braun Melsungen AG